AOD9604 Dosage Guide: How Much Should You Take? (2026)

Key Takeaways

Standard Dosage Range: Typically ranges from 500 mcg to 1,000 mcg daily.

Administration Method: Most commonly administered via subcutaneous injection.

Typical Cycle Length: Cycles can last from 4 to 12 weeks, depending on the research protocol.

Regulatory Status: Not FDA-approved; available for research purposes only.

Medical Supervision: Essential to consult with a healthcare provider for safe and effective use.

How AOD9604 Works in the Body

AOD9604 is a peptide fragment derived from the C-terminal end of human growth hormone (hGH), specifically amino acids 177–191. It is designed to modulate lipid and glucose metabolism pathways, primarily through β-adrenergic and AMPK-related mechanisms. The peptide is known for its potential lipolytic effects, which are believed to occur without the diabetogenic side effects commonly associated with full-length hGH.

Mechanism of Action

AOD9604 works by mimicking the fat-reducing actions of hGH, promoting the breakdown of fats and inhibiting the formation of new fat cells. The peptide binds to receptors involved in lipid metabolism, enhancing the body's ability to utilize stored fat as an energy source. This action is mediated through pathways such as the β-adrenergic receptor and AMPK, which play crucial roles in energy homeostasis and fat oxidation.

AOD9604 has a relatively short half-life, necessitating frequent administration to maintain stable plasma levels. Its bioavailability varies depending on the route of administration, with subcutaneous injections being the most effective due to direct absorption into the bloodstream.

"AOD9604 is reported to mimic the lipolytic properties of growth hormone without the diabetogenic side effects." — PMID 25208511

Standard AOD9604 Dosage Ranges (By Form)

Subcutaneous Injection

Dosage Range: 500 mcg to 1,000 mcg per day.

Frequency: Once daily.

Bioavailability: High, due to direct entry into the bloodstream.

Common Use: Preferred method due to its effectiveness and ease of use.

Oral Administration

Dosage Range: Not commonly used due to low bioavailability.

Frequency: N/A.

Bioavailability: Significantly lower compared to injections, making it less effective.

Intramuscular Injection

Dosage Range: Similar to subcutaneous, but less common.

Bioavailability: Comparable to subcutaneous, but with a slower onset of action.

Subcutaneous administration is the most common form due to its high bioavailability and ease of use. Clinical trials have primarily focused on this method, providing the most robust data for dosage recommendations.

AOD9604 Dosage by Use Case

Obesity Research

Typical Dosage Range: 500 mcg to 1,000 mcg daily.

Administration Method: Subcutaneous injection.

Cycle Length: 12 weeks, as observed in research settings.

Study Reference: Phase IIa trials indicated potential benefits in weight management (PMID 15134286).

Metabolic Research

Typical Dosage Range: 600 mcg to 900 mcg daily.

Cycle Length: 8 to 10 weeks.

Practical Guidance: Many research protocols focus on metabolic markers, observing changes in lipid profiles and glucose metabolism.

Adipocyte Differentiation

Typical Dosage Range: 500 mcg daily.

Cycle Length: 6 to 8 weeks.

Clinical Reference: Studies suggest potential in modulating adipocyte activity without affecting glucose levels (PMID 11673763).

How Long Should You Take AOD9604?

Typical cycle lengths for AOD9604 range from 4 to 12 weeks, depending on the specific research goals. During the initial weeks (1-4), researchers may observe preliminary changes in metabolic markers. By weeks 6 and beyond, more pronounced effects on lipid profiles and weight management can be noted. Tapering is generally not required due to the peptide's non-hormonal nature, and discontinuation typically does not result in rebound effects.

Administration Protocol: How to Take AOD9604

Injection Technique

Needle Gauge: 29 to 31 gauge is recommended for subcutaneous injections.

Injection Sites: Rotate sites between the abdomen, thigh, and upper arm to prevent tissue irritation.

Rotation Schedule: Change injection sites daily.

Storage Requirements

Temperature: Store in a refrigerator between 2°C and 8°C.

Light Sensitivity: Keep away from direct light.

Reconstituted Stability: Use within 14 days after reconstitution.

Step-by-Step Administration

Preparation: Wash hands thoroughly and prepare the injection site with an alcohol swab.

Reconstitution: Follow the reconstitution guide for mixing the peptide with bacteriostatic water.

Drawing the Dose: Use a sterile syringe to draw the prescribed dose.

Injection: Pinch the skin at the chosen site, insert the needle at a 45-degree angle, and inject slowly.

Post-Injection: Dispose of the syringe safely and apply gentle pressure to the site with a cotton swab.

Stacking AOD9604 for Better Results

AOD9604 and BPC-157

Combination: BPC-157 is often combined for its potential in enhancing tissue repair.

Dosing Synergy: AOD9604 (500 mcg) with BPC-157 (200 mcg) daily.

Common Protocols: Used in research focusing on metabolic enhancement and recovery.

AOD9604 and Ipamorelin

Combination: Ipamorelin is used for its growth hormone-releasing properties.

Dosing Synergy: AOD9604 (500 mcg) with Ipamorelin (100 mcg) daily.

Research Use: This stack is explored for synergistic effects on fat metabolism and energy levels.

Factors That Affect Your AOD9604 Dosage

Body Weight and Age

Dosage adjustments may be necessary based on body mass and metabolic rate.

Treatment Goals

Specific research objectives can dictate dosage variations.

Kidney/Liver Function

Individuals with impaired function may require lower doses.

Other Medications

Potential interactions with other substances should be considered.

Individual Response

Variability in response necessitates personalized dosing regimens.

Common Dosing Mistakes to Avoid

Dosing Too High/Too Low

Ensure accurate measurement to prevent adverse effects or lack of efficacy.

Inconsistent Timing

Administer doses at the same time daily to maintain stable plasma levels.

Wrong Injection Site

Use appropriate sites to enhance absorption and reduce irritation.

Not Accounting for Regulatory Status

Remember, AOD9604 is not FDA-approved and is for research purposes only.

Poor Storage/Handling

Improper storage can degrade the peptide and reduce effectiveness.

What the Evidence Does Not Show

While AOD9604 shows promise in preclinical studies, there are significant gaps in long-term safety data and human trials. Current research is predominantly preclinical, with limited dose-response data available. The peptide's effects in humans remain largely unexplored, emphasizing the need for further investigation.

FAQ — Your Top AOD9604 Dosage Questions Answered

Best time of day to take it

Morning administration is common, aligning with the body's natural metabolic rhythms.

What if you miss a dose

Resume the regular schedule the next day without doubling the dose.

Can men and women use the same dose

Yes, dosing is typically based on research goals rather than gender.

Can you stack it with other peptides

Yes, common stacks include BPC-157 and Ipamorelin for synergistic effects.

How long until you see results

Preliminary changes may be observed within 4 weeks, with more significant effects by 8-12 weeks.

Do you need to cycle off

Cycling off is not required due to the peptide's non-hormonal nature.

Is a loading dose needed

No, a loading dose is not necessary for AOD9604.

How to adjust dose if side effects occur

Consult with a healthcare provider to adjust the dose or discontinue use.

Conclusion — Finding the Right Dosage for You

Determining the optimal AOD9604 dosage involves understanding its pharmacokinetics, intended research application, and individual response. While standard dosing ranges provide a starting point, personalized adjustments under medical supervision are crucial for safety and efficacy. Explore more about AOD9604 and related peptides on our platform, and use our clinic finder to connect with qualified providers.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Dosage information is compiled from published research and clinical protocols. Consult a licensed healthcare provider before starting any peptide therapy. Use our clinic finder to locate a qualified provider near you.